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Tuesday, February 28, 2012 435alipid order parameters due to the presence of rhodopsin were much larger in
cholesterol-containing membranes than in cholesterol-free membranes suggest-
ing strongly that the perturbation in the lipid matrix from protein insertion rea-
ches much further away from the protein. This is expected for membranes that
are stiffer due to the presence of cholesterol. The consequences of these find-
ings for lipid mediated shifts in rhodopsin function and rhodopsin-rhodopsin in-
teractions will be discussed.Platform: Cardiac Muscle: Myosin Binding
Proteins
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Cardiac myosin binding protein-C (cMyBP-C) is a thick filament protein that
augments filament stiffness and modulates cardiac contractility through its
phosphorylation. We investigated the effect of cMyBP-C on myosin cross-
bridge kinetics in demembranated papillary muscle strips from non-
transgenic (NTG) and transgenic homozygous mice lacking cMyBP-C (t/t).
Both groups expressed ~100% b-myosin heavy chain isoform due to hypothy-
roidism. Sinusoidal length perturbation analysis at maximal Ca2þ-activation
(pCa 4.8 at 17 C, 0 mM Pi) showed that MgATP-dependent myosin detach-
ment rate (g) increased hyperbolically with MgATP (0.025 to 5 mM), with sat-
urating values of 2.550.2 and 3.950.2 s1 (P<0.01) for NTG and t/t,
respectively. Kinetic analysis of g vs. [MgATP] resulted in a lower [MgATP]50
for NTG than t/t (187545 vs. 361558 mM, P<0.05). As myosin attachment
time (ton) is inversely related to g, ton correspondingly decreased as [MgATP]
increased, with saturating values of 71.355.0 and 44.252.3 ms (P<0.01) for
NTG vs. t/t, respectively. At saturating MgATP, ton decreased as [Pi] increased
in both groups (0-12 mM), although ton remained ~25% longer at each [Pi] for
NTG vs. t/t. Protein kinase-A (PKA) incubation reduced ton ~20% at each [Pi]
for NTG, but did not affect ton for t/t. The longer ton for NTG at saturating
MgATP suggests a longer lived MgADP myosin cross-bridge state when
cMyBP-C is present. The lower [MgATP]50 for NTG further suggests that
cMyBP-C elevates the nucleotide binding pocket affinity for MgATP in addi-
tion to MgADP. cMyBP-C phosphorylation by PKA may diminish this affinity
resulting in a shorter ton. These results support a functional role for cMyBP-C
slowing myosin kinetics, possibly through altered strain-dependent myosin
kinetics due to cMyBP-C supporting a stiffness of the thick filament or myofil-
ament lattice that is diminished with PKA phorphorylation of cMyBP-C.
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We have used double mixing stopped-flow fluorescence to study the effect of
the soluble N-terminal C1C2 domain of cMyBP-C on the activation of product
dissociation from myosin-S1-mdADP-Pi by native porcine thin filaments.
Product dissociation from cardiac actomyosin is an ordered process in which
phosphate dissociation is rate limiting (AM-mdADP-Pi / AM-mdADP /
AM) and can therefore be measured by the rate of mdADP dissociation.
Myosin-S1 was mixed with an equal concentration of the fluorescent ATP an-
alogue, mdATP, and held in a delay line 2 seconds for the nucleotide to bind
and be hydrolyzed (M þ mdATP/ M-mdATP4M-mdADP-Pi). The mix-
ture was subsequently mixed with native cardiac thin filaments, 1 mMMgATP,
1 mM EGTA and expressed mouse cMyBP-C domains C1C2. In control exper-
iments cMyBP-C was either replaced with NEM-S1 (a catalytically inactive
form of myosin-S1, modifed with N-ethylmaleimide, which binds to actin in
the presence of ATP), rigor myosin-S1 (in the absence of ATP) or 0.1 mM
CaCl2. Maximal activation of the rate of product dissociation by cMyBP-C
domains C1C2 is the same as observed with saturating rigor-myosin-S1 or
0.1 mM calcium and greater than observed with NEM-S1. These experiments
were done at physiological ionic strength (0.18 M KAc, 10 mM Mops, 2 mM
MgCl2, pH 7) to eliminate non specific ionic interaction that might occur at
lower ionic strength. Cardiac cMyBP-C domains C1C2 not only bind to actin
at a similar position to rigor myosin-S1 but substoichiometric concentrations
(1 cMyBP-C C1C2 per 7 actin subunits) are as effective as rigor myosin-S1
at activating cardiac thin filament in the absence of calcium.2209-Plat
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We have determined the effects of Myosin binding protein-C (MyBP-C) and its
domains on the microsecond time-scale rotational dynamics of actin, using
time-resolved phosphorescence anisotropy (TPA). MyBP-C is a multi-
domain thick filament-associated modulator of striated muscle contraction,
spanning the interfilament spacing to contact both myosin and actin. Cardiac
(c-) and slow skeletal (ss-) MyBP-C are known substrates for Protein kinase-
A (PKA), and phosphorylation of cMyBP-C alters contractile properties and
myofilament structure. To determine the effects of MyBP-C on actin’s micro-
second structural dynamics, we labeled actin at C374 with erythrosine iodoace-
tamide and performed TPA experiments. The interaction of all three MyBP-C
isoforms with actin increased the final anisotropy (rN) of the TPA decay in
a concentration-dependent manner, indicating restriction of the rotational am-
plitude of actin dynamics. While PKA phosphorylation had little effect on fast
skeletal (fs-) MyBP-C, phosphorylation of cMyBP-C and ssMyBP-C nearly
eliminated the effects of these proteins to restrict actin dynamics, despite no
change in binding affinity with phosphorylation. Skeletal MyBP-C (C1-C10)
affected actin anisotropy at lower concentrations than cMyBP-C (C0-C10),
suggesting that skeletal and cardiac N-terminal MyBP-C interactions with actin
have distinct properties. The effects of truncated cMyBP-C on actin anisotropy
determined that C-terminal domains are important for restricting rotational
dynamics, whereas N-terminal domains are important for regulating this effect.
These MyBP-C-induced changes in actin dynamics may play a role in the
known effects of MyBP-C on the functional actin-myosin interaction. This
work was funded by grants from NIH (F32 HL107039-01 to BAC and T32
AR007612 to DDT).
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Myosin Binding Protein-C (MyBP-C), a family of accessory proteins of stri-
ated muscles, contributes to the assembly and stabilization of thick filaments,
and regulates the formation of actomyosin cross-bridges. Three distinct
MyBP-C isoforms have been characterized; cardiac, slow skeletal and fast
skeletal. The slow isoform, sMyBP-C, consists of four alternatively spliced
forms, variants 1-4 (v1-4) that share common structures and sequences. Var-
iants 1-4 differ, however, in three regions; v1 and v2 contain a 25-residue long
insertion within the NH2-terminus, v3 carries an 18-amino acid long segment
within immunoglobulin domain C7 and v1 contains a unique COOH-terminus
consisting of 26 amino acids, while v4 does not possess any of these inser-
tions. Variants 1-4 are expressed in variable amounts among skeletal muscles,
exhibiting different topographies and potentially distinct functions. To date,
the regulatory mechanisms that modulate the activities of sMyBP-C are
unknown. Using an array of proteomic approaches, we show that sMyBP-C
comprises a family of phosphoproteins that are substrates for PKA and
PKC. The levels of phosphorylated skeletal MyBP-C proteins (i.e. slow and
fast) are increased in mouse dystrophic muscles, although their overall
amounts are decreased. In vitro binding and motility assays indicate that
sMyBP-C modulates the formation of actomyosin cross-bridges through inter-
actions with both actin and myosin. Importantly, the presence of the novel
insertions differentially affects the ability of sMyBP-C variants 1-4 to modu-
late cross-bridges formation. In summary, our studies are the first to show
that sMyBP-C comprises a subfamily of phosphoproteins that differentially
regulate actomyosin crossbridges.
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During recent years it has become increasingly evident that cardiac myosin
binding protein C (cMyBP-C) exerts an important role in regulation of
